237:
231:
324:
280:
314:
319:
304:
329:
273:
334:
200:
309:
128:) in 1975. He continued his career at the university until 1982, when he started working at Janssen Pharmaceutica in
210:
186:
266:
150:
299:
214:
154:
97:
204:
77:
73:
58:
54:
236:
117:
44:
230:
250:
293:
113:
101:
93:
175:
A diarylquinoline drug active on the ATP-synthase of
Mycobacterium tuberculosis
85:
137:
246:
133:
125:
89:
70:
34:
129:
121:
81:
80:. In 2005 he and his team published a discovery about a new di-
187:
Invention: Drug against multidrug-resistant tuberculosis
254:
173:
Andries K, Verhasselt P, Guillemont J, et al. (2005),
50:
40:
30:
23:
132:until 2004. In 2004 he continued his research at
274:
8:
325:Academic staff of the University of Antwerp
281:
267:
20:
153:in the Industry category awarded by the
166:
96:, which promises a shorter and simpler
7:
226:
224:
14:
235:
229:
76:scientist and professor at the
1:
315:Johnson & Johnson people
253:. You can help Knowledge by
177:, Science 307 (5707): 223–27
351:
249:biographical article is a
223:
116:and obtained a PhD at the
211:Koen Andries and his team
320:Ghent University alumni
305:Belgian pharmacologists
151:European Inventor Award
112:Andries graduated as a
215:European Patent Office
155:European Patent Office
330:Belgian veterinarians
205:University of Antwerp
78:University of Antwerp
74:Janssen Pharmaceutica
59:University of Antwerp
57:and professor at the
55:Janssen Pharmaceutica
335:Belgian people stubs
149:2014 winner of the
118:University of Ghent
100:for drug resistant
45:University of Ghent
310:Flemish scientists
262:
261:
64:
63:
16:Belgian scientist
342:
283:
276:
269:
241:
240:
239:
233:
225:
189:
184:
178:
171:
21:
350:
349:
345:
344:
343:
341:
340:
339:
290:
289:
288:
287:
234:
228:
221:
197:
192:
185:
181:
172:
168:
164:
146:
110:
41:Alma mater
26:
17:
12:
11:
5:
348:
346:
338:
337:
332:
327:
322:
317:
312:
307:
302:
292:
291:
286:
285:
278:
271:
263:
260:
259:
242:
219:
218:
208:
196:
195:External links
193:
191:
190:
179:
165:
163:
160:
159:
158:
145:
142:
109:
106:
92:), now called
62:
61:
52:
48:
47:
42:
38:
37:
32:
28:
27:
24:
15:
13:
10:
9:
6:
4:
3:
2:
347:
336:
333:
331:
328:
326:
323:
321:
318:
316:
313:
311:
308:
306:
303:
301:
300:Living people
298:
297:
295:
284:
279:
277:
272:
270:
265:
264:
258:
256:
252:
248:
243:
238:
232:
227:
222:
216:
212:
209:
206:
202:
199:
198:
194:
188:
183:
180:
176:
170:
167:
161:
156:
152:
148:
147:
143:
141:
139:
135:
131:
127:
123:
119:
115:
107:
105:
103:
99:
95:
91:
88:-based drug (
87:
83:
79:
75:
72:
68:
60:
56:
53:
51:Occupation(s)
49:
46:
43:
39:
36:
33:
29:
22:
19:
255:expanding it
244:
220:
201:Koen Andries
182:
174:
169:
114:Veterinarian
111:
102:Tuberculosis
67:Koen Andries
66:
65:
25:Koen Andries
18:
144:Recognition
94:bedaquiline
31:Nationality
294:Categories
162:References
98:treatment
86:Quinoline
138:Mechelen
247:Belgian
134:Tibotec
126:Belgium
90:R207910
71:Belgian
35:Belgian
130:Beerse
108:Career
104:(TB).
245:This
122:Ghent
69:is a
251:stub
82:Aryl
136:in
296::
140:.
124:,
282:e
275:t
268:v
257:.
217:)
213:(
207:)
203:(
157:.
120:(
84:-
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
